Ambrx Biopharma Inc (AMAM)

[surf1944]

This is not a short term play, most P-II trials never move to P-III, even if it does it will be 7-10 years prior to anything coming to market, what to look for is in the coming months does a large pharma company invest in the product or the company. Any drug that is brought to market will costs 100's of millions of dollars to push it forward, AMAM may need to sell shares for years to come, the company will burn through cash at a increasingly rapid rate, again not a short term play. The next big event could very well be the selling of additional shares to take advantage of the higher share price.